We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ovary Transplanted to Arm Preserves Fertility

By HospiMedica staff writers
Posted on 16 Nov 2004
Transplanting an ovary to the upper arm is feasible and preserves hormonal function in women undergoing treatment for cervical cancer, according to a study published in the November 8, 2004, online edition of Cancer.

Although chemotherapy and radiation improve survival and cure rates for women with cervical cancer, such treatments can also cause permanent ovarian failure and infertility during a woman's reproductive years. More...
Cryopreservation of embryos has been successful but there has been no successful cryopreservation or transplantation of oocytes or primordial follicles, necessary for future fertility.

In this second human trial, C. Hilders, M.D., Ph.D., and a gynecologic surgical team at Leiden University Hospital (The Netherlands) developed a new method of autotransplantation to preserve ovarian function in women treated for cervical cancer. This method does not require developing a donor site with an implant over several months, and utilizes a donor site that is easily accessible to noninvasive monitoring and has suitable vasculature.

The team autotransplanted a healthy ovary into the upper arm of a patient, using brachial vessels to establish blood supply, which resulted in a functional ovary. Blood to and from the ovary was adequate to maintain cyclical follicular growth as verified by ultrasound and clinical examination. Moreover, the surgery did not result in additional operating time.

"It seems likely that ovarian autotransplantation will be a realistic goal to achieve for a woman facing cancer, treated by high-dose pelvic radiation, to preserve reproductive and hormonal function, thereby substantially improving the quality of life post-treatment,” concluded the authors.




Related Links:
Leiden U. Hospital

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.